Morgan Stanley’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $717K | Sell |
|
|||||
|
2024
Q2 | $1.68M | Sell |
|
|||||
|
2024
Q1 | $1.97M | Sell |
|
|||||
|
2023
Q4 | $3.11M | Buy |
|
|||||
|
2023
Q3 | $2.59M | Sell |
|
|||||
|
2023
Q2 | $3.54M | Sell |
|
|||||
|
2023
Q1 | $6.97M | Sell |
|
|||||
|
2022
Q4 | $7.32M | Buy |
|
|||||
|
2022
Q3 | $6.13M | Buy |
|
|||||
|
2022
Q2 | $9.43M | Buy |
|
|||||
|
2022
Q1 | $7.29M | Buy |
|
|||||
|
2021
Q4 | $6.74M | Sell |
|
|||||
|
2021
Q3 | $8.29M | Sell |
|
|||||
|
2021
Q2 | $7.19M | Buy |
|
|||||
|
2021
Q1 | $6.5M | Sell |
|
|||||
|
2020
Q4 | $8.56M | Buy |
|
|||||
|
2020
Q3 | $7.09M | Buy |
|
|||||
|
2020
Q2 | $2.45M | Buy |
|
|||||
|
2020
Q1 | $2.27M | Sell |
|
|||||
|
2019
Q4 | $4.25M | Sell |
|
|||||
|
2019
Q3 | $5.42M | Sell |
|
|||||
|
2019
Q2 | $7.92M | Buy |
|
|||||
|
2019
Q1 | $3.7M | Sell |
|
|||||
|
2018
Q4 | $3.61M | Sell |
|
|||||
|
2018
Q3 | $7.33M | Sell |
|
|||||
|
2018
Q2 | $12.6M | Buy |
|
|||||
|
2018
Q1 | $7.55M | Sell |
|
|||||
|
2017
Q4 | $8.91M | Sell |
|
|||||
|
2017
Q3 | $11.4M | Sell |
|
|||||
|
2017
Q2 | $22.9M | Buy |
|
|||||
|
2017
Q1 | $10.7M | Sell |
|
|||||
|
2016
Q4 | $13.7M | Sell |
|
|||||
|
2016
Q3 | $20.5M | Sell |
|
|||||
|
2016
Q2 | $27.7M | Buy |
|
|||||
|
2016
Q1 | $961K | Sell |
|
|||||
|
2015
Q4 | $4.21M | Buy |
|
|||||
|
2015
Q3 | $1.2M | Sell |
|
|||||
|
2015
Q2 | $1.96M | Sell |
|
|||||
|
2015
Q1 | $8.23M | Buy |
|
|||||
|
2014
Q4 | $86K | Buy |
|
|||||
|
2014
Q3 | $65K | Buy |
|
|||||
|
2014
Q2 | $12K | Sell |
|
|||||
|
2014
Q1 | $291K | Buy |
|